NORD Launches CME Challenge to Address Rare Disease Diagnostic Delays
Event summary
- NORD launched the 'Earn Your Stripes: Rare Disease CME Challenge' on February 23, 2026, running through March 31.
- The initiative aims to improve early diagnosis and management of rare diseases among healthcare professionals.
- Over 30 million Americans live with a rare disease, often facing years-long diagnostic delays.
- Medlive has partnered with NORD for six years, delivering education to over 76,000 clinicians, patients, and caregivers.
- 93% of participating clinicians reported positive changes to their practice after previous Medlive/NORD programming.
The big picture
The initiative highlights a systemic problem: a significant gap in rare disease education for clinicians, contributing to delayed diagnoses and poorer patient outcomes. This challenge represents a targeted effort to address this gap, leveraging a proven partnership between NORD and Medlive. The program's reliance on video-based learning suggests a broader trend towards digital continuing education in the healthcare sector.
What we're watching
- Adoption Rate
- The challenge's success hinges on broad adoption by primary care physicians and pediatricians, which will determine the impact on diagnostic timelines and patient outcomes.
- Content Efficacy
- The effectiveness of the video-first CME content will be crucial; Medlive's past success rate (93% positive change) sets a high bar for demonstrable impact.
- Scalability
- NORD's ability to expand the program beyond the initial challenge period and integrate it into ongoing clinician training will be key to long-term impact on rare disease awareness.
